Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer

ISSN： 0257-277X

Source： Immunologic Research, Vol.39, Iss.1-3, 2007-11, pp. : 79-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bilateral Panuveitis following Intravesical BCG Immunotherapy for Bladder Carcinoma

By Uppal Gurmit S. Shah Anish N. Tossounis Charalambos M. Tappin Michael J.

Ocular Immunology and Inflammation, Vol. 18, Iss. 4, 2010-08 ,pp. : 292-296

Informa Healthcare

Access to resources Recommend Favorite

Cancer genetic immunotherapy

By Paul S. Etienne R.

Transfusion Clinique et Biologique, Vol. 9, Iss. 5, 2002-12 ,pp. : 301-321

Elsevier

Access to resources Recommend Favorite

Targeted cytokines for cancer immunotherapy

By Lode Holger Reisfeld Ralph

Immunologic Research, Vol. 21, Iss. 2-3, 2000-06 ,pp. : 279-288

Humana Press, Inc

Access to resources Recommend Favorite

Cancer immunotherapy - broader considerations

By Smyth M.J.

Trends in Immunology, Vol. 22, Iss. 11, 2001-11 ,pp. : 642-642

Elsevier

Access to resources Recommend Favorite

TRAIL: A Potential Agent for Cancer Therapy

Current Molecular Medicine, Vol. 3, Iss. 8, 2003-12 ,pp. : 727-736

Bentham Science Publishers

Access to resources Recommend Favorite